These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9373325)

  • 1. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
    Wu AM; Chen W; Raubitschek A; Williams LE; Neumaier M; Fischer R; Hu SZ; Odom-Maryon T; Wong JY; Shively JE
    Immunotechnology; 1996 Feb; 2(1):21-36. PubMed ID: 9373325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.
    Hu S; Shively L; Raubitschek A; Sherman M; Williams LE; Wong JY; Shively JE; Wu AM
    Cancer Res; 1996 Jul; 56(13):3055-61. PubMed ID: 8674062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.
    Goel A; Beresford GW; Colcher D; Pavlinkova G; Booth BJ; Baranowska-Kortylewicz J; Batra SK
    J Biochem; 2000 May; 127(5):829-36. PubMed ID: 10788792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
    Carmichael JA; Power BE; Garrett TP; Yazaki PJ; Shively JE; Raubischek AA; Wu AM; Hudson PJ
    J Mol Biol; 2003 Feb; 326(2):341-51. PubMed ID: 12559905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
    Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
    Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
    Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
    Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-chain antibodies in pancreatic cancer.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
    Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
    J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
    Pietersz GA; Patrick MR; Chester KA
    J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein.
    Michael NP; Chester KA; Melton RG; Robson L; Nicholas W; Boden JA; Pedley RB; Begent RH; Sherwood RF; Minton NP
    Immunotechnology; 1996 Feb; 2(1):47-57. PubMed ID: 9373327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
    Wu AM; Yazaki PJ; Tsai Sw; Nguyen K; Anderson AL; McCarthy DW; Welch MJ; Shively JE; Williams LE; Raubitschek AA; Wong JY; Toyokuni T; Phelps ME; Gambhir SS
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8495-500. PubMed ID: 10880576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.
    Yazaki PJ; Kassa T; Cheung CW; Crow DM; Sherman MA; Bading JR; Anderson AL; Colcher D; Raubitschek A
    Nucl Med Biol; 2008 Feb; 35(2):151-8. PubMed ID: 18312824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
    Willuda J; Honegger A; Waibel R; Schubiger PA; Stahel R; Zangemeister-Wittke U; Plückthun A
    Cancer Res; 1999 Nov; 59(22):5758-67. PubMed ID: 10582696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
    Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
    Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.